Back HIV/AIDS

HIV / AIDS

AIDS 2016: Gains in Curbing HIV Could Be Lost Without Continued Commitment

Participants at the 21st International AIDS Conference (AIDS 2016), taking place this week in Durban, South Africa, reviewed the remarkable gains that have been made in access to HIV treatment and new prevention tools since the conference was last held here 16 years ago. But researchers, activists, and government leaders agreed that this progress could be reversed if stakeholders do not commit to increased funding and respect for the human rights of key populations at risk.

alt

AIDS 2016: International AIDS Conference Starts Next Week in Durban

The 21st International AIDS Conference (AIDS 2016) opens next Monday, July 18, in Durban, South Africa, 16 years after the groundbreaking conference in the same city that put the spotlight on global access to new life-saving treatment for people living with HIV and AIDS. This year's theme -- Access, Equity, Rights Now -- recognizes the barriers that still need to be overcometo achieve universal access. HIVandHepatitis.comand collaborator Aidsmap.comwill provide on-site coverage starting on July 17. Follow @HIVandHepatitison Twitter and visit our AIDS 2016 conference page (coming soon) or Facebook pagefor the latest news.

alt

HIV Treatment Reduces HIV Transmission by 77% among South African Couples

Antiretroviral treatment reduced the risk of HIV transmission by 77% in serodiscordant couples in rural South Africa, a population-based study carried out in the province of KwaZulu-Natal has shown. The findings were recently published in the advance online edition of Clinical Infectious Diseases. The investigators say that their findings provide a real-life estimate of the impact of antiretroviral treatment on HIV transmission under normal community conditions.

alt

ASM Microbe 2016: Switching from Tenofovir DF to TAF Improves Bone and Kidney Safety

People with HIV who switched from the older tenofovir disoproxil fumarate (TDF) formulation to tenofovir alafenamide (TAF) were more likely to maintain viral load suppression and showed improvements in bone density and kidney function biomarkers, according studies presented at the 2016 ASM Microbe conference last month in Boston.

alt

ART Reduces Opportunistic Illnesses in Children and Adults with HIV

A pair of comprehensive reviews supported by the World Health Organization (WHO) have found that prompt initiation of antiretroviral therapy (ART) is associated with a lower risk of developing opportunistic infections and other HIV-related illnesses in children and adults living with HIV. Both reviews were published in the June 15 edition of Clinical Infectious Diseases.

alt

Mild Neurological Impairment Is Common During Early HIV Infection

People with HIV infection often have neurological signs and symptoms very soon after becoming infected -- even before they develop antibodies that show up on a test -- but these are typically mild to moderate and resolve after starting effective antiretroviral therapy (ART), according to a study published in the June 10 advance online edition of Neurology. These findings provide further evidence for starting treatment as soon as possible after HIV diagnosis.

alt

Retention in Care Drives Adherence in PrEP Implementation Programs

The proportion of gay and bisexual men who started and remained on Truvada for pre-exposure prophylaxis (PrEP) varied in real-world implementation programs in 3 mid-size U.S. cities, but retention in care was "consistently suboptimal," according to a study described in the June 13 online edition of the Journal of the International AIDS Society. Among those who did remain in care, however, adherence was good.

alt